$PRCT News

PROCEPT BioRobotics (PRCT) Stock May Be Fully Priced On Cash Flow Hopes

PROCEPT BioRobotics® to Report Third Quarter 2026 Financial Results on November 4th, 2026

PROCEPT BioRobotics (PRCT) Could Be 70% Undervalued On Lawsuit And Board Change

Barclays Initiates Coverage On PROCEPT BioRobotics with Overweight Rating, Announces Price Target of $30

Does New Director and Discounting Lawsuit Change The Bull Case For PROCEPT BioRobotics (PRCT)?

Procept BioRobotics CEO Buys 23,900 Shares Amid 48% Stock Decline. What Does This Tell Investors?

PROCEPT BioRobotics® to Attend the Baird 2026 Global Healthcare Conference on September 15, 2026

PROCEPT BioRobotics (PRCT) Q2 2026 Earnings Call Transcript

PROCEPT BioRobotics (PRCT) Stock Sees Fair Value Falls As Analysts Cut Growth Views

TD Cowen Maintains Buy on PROCEPT BioRobotics, Lowers Price Target to $28

PROCEPT BioRobotics Corporation Q2 2026 Earnings Call Summary

Piper Sandler Maintains Overweight on PROCEPT BioRobotics, Lowers Price Target to $25

Evercore ISI Group Maintains Outperform on PROCEPT BioRobotics, Lowers Price Target to $23

William Blair Downgrades PROCEPT BioRobotics to Market Perform

PROCEPT BioRobotics Corp (PRCT) (Q2 2026) Earnings Call Highlights: Strong HYDROS Demand Drives ...

PROCEPT BioRobotics Q2 Earnings Call Highlights

PROCEPT BioRobotics Corporation (PRCT) Q2 2026 Earnings Call Transcript

Procept BioRobotics (NASDAQ:PRCT) Q2 In Line, But Unchanged Guidance Sinks Shares

PROCEPT BioRobotics Reports Second Quarter 2026 Financial Results

PROCEPT BioRobotics Affirms FY2026 Sales Guidance of $390.000M-$410.000M vs $397.424M Est